What daily dose of citrus bergamot do studies use, and is there a cycle?

Strengths and labels
ProductStrengthLabelled daily amount
Swanson bergamot extract capsule3500 mg of Bergavit bergamot fruit extract per veggie capsule, standardized to 25% flavonoidsOne veggie capsule per day with water, as a dietary supplement; not intended for use in children
Designs for Health BergaVin capsules6400 mg of bergamot as Bergavit 40, standardized to contain 39% flavonoids, with 200 mg of Vinia red grape powder; the leaflet does not say whether this is per capsule or per 2 capsules2 capsules daily with a meal, or as directed by a health-care practitioner

Strengths and labels

The table is set at the top of the page

The two leaflets give different capsule counts. Searches of DailyMed and of EFSA, EMA, NIH ODS and Health Canada pages found no oral drug label or regulator page for bergamot, and the products found are capsules, tablets and a juice, none a powder to mix. The only liquid is the bergamot juice in registry entry NCT05589636, 400 cc/die (35% in water) for 12 weeks in an estimated 44 healthy subjects, with no concentration in mg per mL given.7

Doses and schedules in trials

The trials below each used a different preparation, so their doses are not directly comparable.

TrialDose and schedulePeopleLength
Fogacci phytocomplex trial1700 mg/day or 350 mg/day of a water extract of bergamot fruit, or placebo90 adults, 30 per group, healthy volunteers with the features of metabolic syndrome12 weeks
Fogacci bergamot-and-opuntia trial82 tablets a day of a nutraceutical compound (each tablet 200 mg of Brumex bergamot phytocomplex with 150 mg of Opuntia extract, 400 mg of plant sterols and 12.5 mg of thiamine), 2 of placebo, or one of each, taken in the evening, before sleeping75 hypercholesterolaemic subjects, 25 per arm12 weeks
Capomolla 2019 trial2650 mg (one capsule) or 1300 mg (2 capsules) daily of bergamot polyphenol extract complex (BPE-C), a juice-derived formulation enriched with flavonoids and pectins, or placeboFifty-two obese patients with atherogenic index of plasma over 0.34 and mild hyperglycemia, 17, 18 and 17 per arm; fifteen per group completed90 days
Gliozzi 2013 open-label trial41000 mg/daily orally of bergamot polyphenolic fraction (BPF) alone, or with rosuvastatin 10mg/daily, against placebo and rosuvastatin 10 or 20mg/daily alone77 patients with elevated serum LDL-C and triglycerides, 15 in each BPF arm30 days
Toth study5One arm, with no placebo group: Bergavit extract at a fixed dose daily (150 mg of flavonoids)Eighty subjects (42 men and 38 women) with moderate hypercholesterolemia6 months

The trials, registry entries and labels name oral tablets, capsules or a juice, and none states an injection or site.47 Trials ran continuously, and no on/off cycle or cycle length is stated in the saved text of the review, the trials or the registry entries.

What is not settled

Registry entry NCT02205567 (University of Palermo), an observational study of 160 adult subjects with dyslipidemia, lists two groups, 500mg/day and 1000mg/day of a bergamot-derived product, with plasma lipids to be measured at baseline and after 6 months.9

A systematic review and meta-analysis of bergamot trials by Chambari and colleagues rates GRADE certainty as low or very low for all outcomes and calls for trials with prespecified doses and treatment durations.10

Safety and interactions

In the Capomolla 2019 trial, which reports BPE-C as well tolerated, there were few reports of moderate gastric pyrosis, 2 in the low-dose group and 1 in the high-dose group, while headache (2) and constipation (1) were reported in the placebo group.2

The Swanson label says it is not intended for use in children and advises consulting a healthcare provider before use if pregnant, nursing, taking prescription medication or having a medical condition.3 A 1998 laboratory study by He and colleagues found that bergamottin, the major furanocoumarin in grapefruit juice, inactivated the drug-metabolizing enzyme P450 3A4 in a reconstituted system of purified enzyme, and it did not test bergamot supplements.11 Apart from the Gliozzi trial, which gave the polyphenolic fraction with rosuvastatin 10mg/daily and reports that the addition significantly enhanced the rosuvastatin-induced effect on serum lipids compared to rosuvastatin alone, no saved source tests bergamot supplements against drugs.4

Storage

The Swanson leaflet says to store in a cool, dry place and not to use if the seal is broken.3 It gives no temperature and no condition after opening, and no saved source gives stability data.

Frequently asked questions

Is there a Resona citrus bergamot dose?

The searches returned nothing for a product named Resona or Velora citrus bergamot.

References

  1. PubMed Central. Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial. 2023. pmc.ncbi.nlm.nih.gov
  2. PubMed Central. Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols. 2019. pmc.ncbi.nlm.nih.gov
  3. NIH Dietary Supplement Label Database. Minimum 25% Flavonoids Extract. api.ods.od.nih.gov
  4. PubMed. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. 2013. pubmed.ncbi.nlm.nih.gov
  5. PubMed Central. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study. 2016. pmc.ncbi.nlm.nih.gov
  6. Designs for Health. BergaVin™. designsforhealth.com
  7. ClinicalTrials.gov. NCT05589636: Effect of Bergamot Juice on LDL Cholesterol Level in Healthy Subjects. 2023. clinicaltrials.gov
  8. PubMed Central. Comparative effect of a nutraceutical compound based on a flavonoid complex from bergamot on plasma lipids, glucose metabolism, and liver enzymes: a 3-arm, double-blind, placebo-controlled, randomized clinical trial. 2022. pmc.ncbi.nlm.nih.gov
  9. ClinicalTrials.gov. NCT02205567: Bergamot and Cardio-Metabolic Risk Factors. 2015. clinicaltrials.gov
  10. PubMed Central. Bergamot ( Citrus bergamia ) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta‐Analysis. 2026. pmc.ncbi.nlm.nih.gov
  11. PubMed. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. 1998. pubmed.ncbi.nlm.nih.gov